HALO logo
halo search icon
Myriad Genetics, Inc.

US$3.81

Price Change Indicator
0.26 (7.32%)
Myriad Genetics, Inc.
MYGN · NAS

Myriad Genetics, Inc.

Start Trading MYGN for Free

US$3.81

Price Arrow0.26 (7.32%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusConsensus CheapHALO AllHALO Earnings MomentumHALO Growth
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Myriad Genetics, Inc. Overview

MYGN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Weak

Garp

Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Weak

Balance Sheet

Very Strong

About MYGN

icon
icon

Telephone

1.801.584.3600

icon

Address

322 North 2200 West, Salt Lake City, UT 84116

Description

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

MYGN Price Chart

Key Stats

Market Cap

US$335.29M

PE

840.90

EV/EBITDA

12.3

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 3.53 - 8.59

Trade Value (12mth)

US$2,136,006.00

1 week

-0.84%

1 month

-28.86%

YTD

-42.18%

1 year

-12.78%

All time high

50.44

Key Fundamentals

EPS 3 yr Growth

184.40%

EBITDA Margin

-1.60%

Operating Cashflow

$2m

Free Cash Flow Return

0.30%

ROIC

-52.30%

Interest Coverage

-1.30

Quick Ratio

2.30

Other Data

Shares Outstanding (Fully Diluted)

94m

HALO Sector

Healthcare

Next Company Report Date

02-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

MYGN Announcements

Latest Announcements

DateAnnouncements
06 May 26
06 May 26
06 May 26
06 May 26
06 May 26

MYGN Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-3.18-1.41-3.95locklocklock
EPS (Fully Diluted)
 $locklocklocklock-3.18-1.41-3.95locklocklock
Growth
 %locklocklocklock-128.855.8-181.2locklocklock
PE
 XlocklocklocklockN/A107.4840.9locklocklock
EV/EBITDA
 XlocklocklocklockN/A32.512.3locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Myriad Genetics, Inc. (MYGN:NAS)?
Halo FAQ
The current share price of Myriad Genetics, Inc. (MYGN:NAS) is USD$3.81.
What is the 52-week high share price for Myriad Genetics, Inc. (MYGN:NAS)?
Halo FAQ
The 52-week high share price for Myriad Genetics, Inc. (MYGN:NAS) is USD$8.59.
What is the 52-week low share price for Myriad Genetics, Inc. (MYGN:NAS)?
Halo FAQ
The 52-week low share price for Myriad Genetics, Inc. (MYGN:NAS) is USD$3.53.
What is the dividend yield for Myriad Genetics, Inc. (MYGN:NAS)?
Halo FAQ
Myriad Genetics, Inc. (MYGN:NAS) does not pay a dividend.
What was Myriad Genetics, Inc. (MYGN:NAS) last dividend payment?
Halo FAQ
Myriad Genetics, Inc. (MYGN:NAS) does not pay a dividend.
What is the franking level for Myriad Genetics, Inc. (MYGN:NAS)?
Halo FAQ
Myriad Genetics, Inc. (MYGN:NAS) has a franking level of 0.00%.
In which sector is Myriad Genetics, Inc. (MYGN:NAS) classified?
Halo FAQ
Myriad Genetics, Inc. (MYGN:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Myriad Genetics, Inc. (MYGN:NAS)?
Halo FAQ
The current P/E ratio for Myriad Genetics, Inc. (MYGN:NAS) is 840.90.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial